By early 2026, FDA had publicly announced enforcement actions against multiple compounded GLP-1 telehealth platforms, and in April 2026 formally proposed removing semaglutide, tirzepatide, and liraglutide from the 503B outsourcing bulks list - with a public comment period running through June 2026
However, coverage decisions and Ozempic costs may vary among insurance providers
Hydrosoluble molecules with free radical scavenging properties such as ascorbic acid, albumin, bilirubin, urates and thiols, liposoluble coenzyme Q10, and vitamin E interfere with the lipid peroxidation by neutralizing the free radicals
With branded options now deemed fully available, the agency plans to crack down on compounded GLP-1 medications as soon as this month a regulatory pivot that could reshape access for patients like Rising overnight
Weight loss reduces apnoea severity in most people, and even modest weight loss can make a measurable difference